Imagine two initiatives competing for investment at an MGA. One would double the number of submissions the underwriting team can process. The other would shorten the time required to identify, investigate and respond to deteriorating portfolio performance.
The first has an immediately visible growth story. The second forces a harder question: how much business might the MGA write before recognizing that an assumption needs to change? As production accelerates, the speed and quality of feedback into underwriting become increasingly important constraints on responsible growth.
Growth is strong. The benefits are uneven.
Conning estimates that U.S. MGA premium reached approximately $128 billion in 2025. Its July 2026 research describes MGAs taking a more central coordinating role across underwriting expertise, distribution, technology and capital. Statutory filings captured $102.6 billion of MGA direct premium written, up 12% from 2024; Conning’s broader estimate also incorporates Lloyd’s business and other premium not fully reflected in statutory reporting.
Europe offers another perspective. Howden Re estimates that “scale-ready and established” independent MGAs—businesses with at least €25 million in gross written premium and a demonstrable track record—represent around 30% of European MGA entities but generate 70% to 85% of total premium. That concentration does not prove that superior analytics caused those firms to succeed. It does show that a growing market does not create equivalent outcomes for every participant.
AM Best adds a further consideration: capacity providers are becoming more selective, with greater focus on long-term underwriting quality and loss-ratio stability. Its June report points to moderating excess-and-surplus growth and a maturing MGA sector that will require greater portfolio discipline and effective technology adoption. The practical implication is that growth plans need a credible explanation of how control will keep pace with volume and complexity.
The bottleneck may sit before the analysis
The Broadstone–InsTech report “MGAs and Actuaries in 2026” is based on 98 responses from UK MGAs. The research finds that actuarial and analytical expertise is embedded in common activities including underwriting performance, pricing adequacy and claims development.
Yet the report says practitioners often attribute 40% to 50% of actuarial project effort to data preparation. Broadstone identifies that estimate as practitioner and supplementary market research rather than a measured average across every respondent. Even with that qualification, it exposes an important distinction: access to analytical expertise does not mean the expertise can be applied promptly.
An MGA may have experienced underwriters, modern policy systems and sophisticated models while still spending material time reconciling claims feeds, aligning definitions or reconstructing earlier decisions. The Insurance Network describes the same scaling friction: fragmented data and manual processes can make portfolio performance harder to explain as an MGA grows.
The leadership question is not simply how much analytical capability the business owns. It is how much of that capability is consumed preparing to make a decision.
Put a value on oversight lag
Consider a hypothetical program writing $120 million of annual premium at a steady pace. Assume information that warrants an underwriting change becomes available, but reconciliation, investigation, approval and implementation take three months. Approximately $30 million of premium could be written during that interval.
If management later estimates that the affected cohort carries an expected loss ratio five percentage points above the level achievable under revised underwriting, the difference represents $1.5 million of expected losses. This is illustrative arithmetic, not an estimate of typical MGA leakage. It assumes an effective intervention was available and applies only to affected business. The economic burden would ultimately depend on the contractual relationship among the MGA, insurer and reinsurers.
The example nevertheless changes the investment conversation. The commercial cost of delay is not limited to the employee hours spent producing a report. It includes the risk written while the organization is learning what it needs to change.
Measure the path from evidence to action
MGA boards should track the elapsed time from an actionable signal becoming available to an approved response taking effect. Call it oversight lag. Break it into three intervals so management can distinguish different causes of delay.
- Availability: when does relevant information reach the MGA in a usable form?
- Interpretation: how long does it take to establish whether the signal warrants action?
- Execution: how long until an approved change reaches underwriting practice?
Each interval has a different remedy. A late claims feed, an analytical backlog and a slow authority process should not produce the same technology purchase. Pair elapsed time with the volume of affected business written during the interval. That converts a generic reporting metric into a measure of commercial exposure.
Oversight lag is a proposed management approach, not an established industry benchmark. Appropriate thresholds will vary by class, claims maturity, portfolio size and the credibility of the evidence. Long-tail uncertainty cannot be eliminated by refreshing a dashboard more frequently, and acting too quickly on immature experience can be as damaging as waiting too long.
Three decisions for the next board meeting
First, require a monitoring plan with every material growth proposal. For a new product, territory or distribution relationship, identify the assumptions that could fail, the evidence that would reveal a problem and the person authorized to respond. Agree in advance on the conditions that would trigger investigation, tighter terms, reduced appetite or a pause—before production targets create pressure to explain away adverse signals.
Second, evaluate AI investments against both production and oversight. If a proposal increases submission throughput, ask whether the organization can monitor the resulting change in business mix, exceptions and concentrations. Faster intake can shift work downstream. The investment case should account for that demand and show that the MGA can understand the additional business it becomes capable of writing.
Third, rehearse a difficult capacity conversation before renewal. Select one material segment and ask a team to reconstruct the underwriting rationale from the underlying records. Can it explain what changed, separate evidence from assumption, reproduce the analysis and show what action followed? Then ask whether that explanation would remain accessible if a key employee left or a service provider changed.
The next capacity discussion
An MGA cannot promise that every underwriting assumption will prove correct. It can show how it detects emerging problems, evaluates uncertain evidence and responds within its authority. That is a more substantive foundation for a capacity conversation than a growth target accompanied by a technology roadmap.
At the next board meeting, put two measures beside each other: how quickly can the organization write more business, and how quickly can it recognize and change the business it should write differently? The gap between them deserves an owner, a measure and an investment decision.
Research note: the sources below cover different U.S., UK and European populations and definitions. They offer complementary perspectives rather than a directly comparable dataset. Oversight lag and the illustrative financial scenario are MGA Index proposals, not findings from those studies.
Questions for the room
- What is the longest part of our path from evidence to underwriting action?
- How much premium could we write while resolving a material portfolio question?
- Does each growth proposal identify the signals that would cause us to change course?
- Are we investing as deliberately in feedback velocity as we are in submission velocity?
Sources and methodology
This analysis draws on the public sources below. Company-specific disclosures are treated as examples, not market-wide evidence. Interpretation is MGA Index’s own.
1 Conning — U.S. MGA Premiums Reach $128 Billion as Market Evolution Continues 2 Howden Re — Filtered for quality: a refined view of Europe’s MGA market 3 AM Best — Managing General Agents Adapt to Changing Demands and Added Scrutiny 4 Broadstone and InsTech — MGAs and Actuaries in 2026: The State of the Market 5 The Insurance Network — The evolving MGA market and the role of technology, data and AIMGA Index Newsroom
The MGA Index Newsroom produces independent reporting and analysis for leaders across the delegated insurance market. Our work connects public evidence to the operating and strategic decisions facing MGA leadership teams.
Newsroom analysis distinguishes reported facts from interpretation and identifies the public sources supporting material claims. Relevant relationships or potential conflicts are disclosed with the coverage.
Editorial standards and corrections